DHR
50
-2
NAVI
32
-6
TDC
59
-8
NWSA
47
-3
TXN
43
-5
SWKS
37
-5
ABBV
44
-2
DIS
49
-9
TGT
44
-5
QRVO
22
-7
HPQ
52
-7
COF
54
-3
CCL
44
-3
FFIV
67
-2
LB
49
37
ED
52
2
FRT
41
-4
AEP
51
-2
STX
57
-2
HRL
26
2
DHR
50
-2
NAVI
32
-6
TDC
59
-8
NWSA
47
-3
TXN
43
-5
SWKS
37
-5
ABBV
44
-2
DIS
49
-9
TGT
44
-5
QRVO
22
-7
HPQ
52
-7
COF
54
-3
CCL
44
-3
FFIV
67
-2
LB
49
37
ED
52
2
FRT
41
-4
AEP
51
-2
STX
57
-2
HRL
26
2
Financhill
Back

EyePoint Pharmaceuticals Vs. Regenxbio Industry Stock Comparison

Sell
40

EYPT
EyePoint Pharmaceuticals

Last Price:
8.23
Seasonality Move:
-9.25%
Sell
21

RGNX
Regenxbio

Last Price:
10.14
Seasonality Move:
10.27%
Sell
40
EyePoint Pharmaceuticals (EYPT) is a Sell

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $8.01. The Score for EYPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
21
Regenxbio (RGNX) is a Sell

Is Regenxbio a Buy, Sell or Hold?

  • The current Regenxbio [RGNX] share price is $10.22. The Score for RGNX is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • RGNX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $8.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

RGNX Stock Price Chart

What is Regenxbio's stock price today?

  • The Regenxbio share price today is $10.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGNX is experiencing slight buying pressure.

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 42.06 Sell
Chaikin Money Flow: 232993 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.06 - 8.9) Sell
Bollinger Bands (100): (8.03 - 10.53) Sell

RGNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.43 Sell
Relative Strength Index (14 RSI): 32.82 Sell
Chaikin Money Flow: 24861 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.94 - 12.44) Sell
Bollinger Bands (100): (11.31 - 14.31) Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.22 Sell
20-day SMA: 8.42 Sell
50-day SMA: 8.66 Sell
200-day SMA: 15.98 Sell
8-day EMA: 8.2 Sell
20-day EMA: 8.4 Sell
50-day EMA: 8.83 Sell
200-day EMA: 12.03 Sell

RGNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.95 Sell
20-day SMA: 11.67 Sell
50-day SMA: 12.23 Sell
200-day SMA: 15.33 Sell
8-day EMA: 10.93 Sell
20-day EMA: 11.48 Sell
50-day EMA: 12.07 Sell
200-day EMA: 14.69 Sell

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.94 per share.

Regenxbio Earnings Growth & RGNX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $3.83 per share.

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regenxbio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):